Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Medical Microbiology and Immunology
Erschienen in: Medical Microbiology and Immunology 4/2004

01.11.2004 | Original Investigation

Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus

verfasst von: Andreas Lucht, Roland Grunow, Christian Otterbein, Peggy Möller, Heinz Feldmann, Stephan Becker

Erschienen in: Medical Microbiology and Immunology | Ausgabe 4/2004

Einloggen, um Zugang zu erhalten

Abstract

Ebola virus (EBOV) causes severe outbreaks of Ebola hemorrhagic fever in endemic regions of Africa and is considered to be of impact for other parts of the world as an imported viral disease. To develop a new diagnostic test, monoclonal antibodies to EBOV were produced from mice immunized with inactivated EBOV species Zaire. Antibodies directed against the viral glycoprotein GP were characterized by ELISA, Western blot and immunofluorescence analyses. An antigen capture ELISA was established, which is specific for EBOV-Zaire and shows a sensitivity of approximately 103 plaque-forming units/ml. Since the ELISA is able to detect even SDS-inactivated EBOV in spiked human sera, it could complement the existing diagnostic tools in the field and in routine laboratories where high containment facilities are not available.
Literatur
1.
Baize S, Leroy EM, Courbot MC, Capron M, Landsoud-Soukate J, Debré P, Fisher-Hoch SP, McCormick JB, Georges AJ (1999) Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 5:423–426CrossRefPubMed
2.
Becker S, Feldmann H, Will C, Slenczka W (1992) Evidence of occurrence of filoviruses antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? Med Microbiol Immunol 181:43–55PubMed
3.
Becker S, Klenk HD, Muhlberger E (1996) Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells. Virology 225:145–55CrossRefPubMed
4.
Becker S, Rinne C, Hofsass U, Klenk HD, Muhlberger E (1998) Interactions of Marburg virus nucleocapsid proteins. Virology 249:406–417CrossRefPubMed
5.
Borisevich IV, Mikhailov VV, Potryvaeva NV, Malinkin IN, Kirillov AP, Krasnianskii VP, Markov VI, Makhlai AA, Lebedinskaia EV (1996) Development of the immunoenzyme test-system for detection of Ebola virus antigen. Vopr Virus 41:232–234PubMed
6.
Bowen ETW, Platt GS, Lloyd G, Baskerville A, Harris WJ, Vella EE (1977) Viral haemorrhagic fever in southern Sudan and northern Zaire. Lancet I:571–572CrossRef
7.
Centers for Disease Control (1989) Ebola virus infection in imported primates—Virginia 1989. MMWR Morb Mortal Wkly Rep 38:831–832PubMed
8.
Centers for Disease Control and Prevention (1996) Ebola-Reston virus infection among quarantined primates—Texas 1996. MMWR Morb Mortal Wkly Rep 45:314–316PubMed
9.
Edmond RTD, Evans B, Bowen ETW, Lloyd G (1977) A case of Ebola virus infection. Br Med J 2:541–544PubMed
10.
Feldmann H, Slenczka W, Klenk HD (1996) Classification, structure, and replication of filoviruses. Curr Top Microbiol Immunol 236:1–22
11.
Feldmann H, Volchkov VE, Volchkova VA, Stroher U, Klenk HD (2001) Biosynthesis and role of filovirus glycoproteins. J Gen Virol 82:2839–2848PubMed
12.
Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner PL (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269:2550–2561PubMed
13.
Geisbert TW, Jahrling PB (1995) Differentiation of filoviruses by electron microscopy. Virus Res 39:129–150CrossRefPubMed
14.
Grunow R, Giese R, Porstmann T, Doepel H, Haensel K, Bähr R von (1990) Development and biological testing of human and murine monoclonal antibodies against HIV antigens. Z Klin Med 45:367–369
15.
Ivanoff B, Duquesnoy P, Languillat G, Saluzzo JF, Georges A, Gonzalez JP, McCormick J (1982) Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué. Trans R Soc Trop Med Hyg 76:719–720PubMed
16.
Jahrling PB, Geisbert TW, Dalgard DW, Johnson ED, Ksiazek TG, Hall WC, Peters CJ (1990) Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 335:502–505PubMed
17.
Johnson BK, Wambui C, Ocheng D, Gichogo A, Oogo S, Libondo D, Gitau LG, Tukei PM, Johnson ED (1986) Seasonal variation in antibodies against Ebola virus in Kenyan fever patients. Lancet I:1160CrossRef
18.
Johnson KM, Webb PA, Lange JV, Murphy FA (1977) Isolation and partial characterization of a new virus causing acute haemorrhagic fever in Zaire. Lancet I:569–571CrossRef
19.
Johnson KM, Elliott LH, Heymann DL (1981) Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys. J Clin Microbiol 14:527–529PubMed
20.
Kearney JF, Radbruch A, Liesegang B, Rajewsky K (1979) A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immun 123:1548–1550PubMed
21.
Kiley MP, Bowen ETW, Eddy GA, Isaacson M, Johnson KM, McCormick JB, Murphy FA, Pattyn SR, Peters D, Prozesky OW, Regnery RL, Simpson DIH, Slenczka W, Sureau P, van der Groen G, Webb PA, Wulff H (1982) Filoviridae: a taxonomic home for Marburg and Ebola virus? Intervirology 18:24–32PubMed
22.
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497PubMed
23.
Ksiazek TG, Rollin PE, Jahrling PB, Johnson E, Dalgard DW, Peters CJ (1992) Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol 30:947–950PubMed
24.
Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swanepoel R, Burt FJ, Leman PA, Khan AS, Rowe AK, Mukunu R, Sanchez A, Peters CJ (1999) Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179 [Suppl 1]:177–187
25.
LeGuenno B, Formentry P, Wyers M, Gounon P, Walker F, Boesch C (1995) Isolation and partial characterization of a new strain of Ebola virus. Lancet 345:1271–1274CrossRefPubMed
26.
Lenz O, Klenk HD, Slenczka W, Feldmann H (1998) Infektionen durch Marburg- und Ebolavirus. Epidem Bull 45:317–319
27.
Leroy EM, Baize S, Lu CY, McCormick JB, Georges AJ, Georges-Courbot MC, Lansoud-Soukate J, Fisher-Hoch SP (2000) Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol 60:463–467CrossRefPubMed
28.
Lucht A, Grunow R, Möller P, Feldmann H, Becker S (2003). Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus. J Virol Methods 111:21–28CrossRefPubMed
29.
Maryama T, Rodriguez LL, Jahrling PB, Sanchez A, Khan AS, Nichol ST, Peters CJ, Parren PW, Burton DR (1999). Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol 73:6024–6030PubMed
30.
Merzlikin NV, Chepurnov AA, Istomina NN, Ofitserviv VI, Vorobéva MS (1995) Development and application of an immunoenzyme test system for diagnosing Ebola fever. Vopr Virus 40:31–35PubMed
31.
Mühlberger E, Sanchez A, Randolf A, Will C, Kiley MP, Klenk HD, Feldmann H (1992) The nucleotide sequence of the L gene of Marburg virus, a filovirus, homologies with paramyxoviruses and rhabdoviruses. Virology 187:534–537PubMed
32.
Nakane PK, Kawaoi A (1974) Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem 22:1084–1091PubMed
33.
Niikura M, Ikegami T, Saijo M, Kurane I, Miranda ME, Morikawa S (2001) Detection of Ebola viral antigen by enzyme-linked immunosorbentassay using a novel monoclonal antibody to nucleoprotein. J Clin Microbiol 39:3267–3271CrossRefPubMed
34.
Okome-Nkoumou M, Kombila M (1999) A case of Ebola haemorrhagic fever in Libreville, fatal after evacuation to South Africa. Med Trop 59:411
35.
Pattyn SR, Jacob W, Van Der Groen G, Piot P (1977) Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire. Lancet I:573–574CrossRef
36.
Rollin PE, Ksiazek TG, Jahrling PB, Haines M, Peters CJ (1990) Detection of Ebola-like viruses by immunofluorescence. Lancet 336:1591PubMed
37.
Rowe AK, Bertolli J, Khan AS, Mukum R, Muyembe-Tamfun JJ, Bressler D, Williams AJ, Peters CJ, Rodriguez L, Feldmann H, Nichol ST, Rollin PE, Ksiazek TG (1999) Clinical, virologic, and immunologic follow up of convalescent Ebola haemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis 179 Suppl 1:S28-S35
38.
Sadek RF, Khan AS, Stevens G, Peters CJ, Ksiazek TG (1999) Ebola haemorrhagic fever, Democratic Republic of the Congo, 1995: Determinants of survival. J Infect Dis 179 [Suppl 1]:S24–S27
39.
Sanchez A, Feldmann H (1996) Detection of Marburg and Ebola virus infections by polymerase chain reaction assays. In: Becker Y (ed) Frontiers of Virology—Diagnosis of human viruses by polymerase chain reaction technology. Springer, Berlin Heidelberg New York, pp 411–418
40.
Sanchez A, Trappier SG, Mahy BWJ, Peters CJ, Nichol ST (1996) The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through descriptional editing. Proc Natl Acad Sci USA 93:3602–3607PubMed
41.
Slenczka W, Shu HL, Piepenburg G, Siegert R. (1968) “Marburg virus” antigen demonstration by immunofluorescence in organs of infected guinea pigs. Dtsch Med Wochenschr 93:612–616PubMed
42.
Slenczka W, Rietschel M (1984) Seroepidemiologische Untersuchungen über das Vorkommen von Antikörpern gegen Marburg- und Ebola-Virus. Mitt Oest Ges Tropenmed Parasitol 6:53–60
43.
Sutter G, Ohlmann M, Erfle V (1995) Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett 371:9–12CrossRefPubMed
44.
Van der Waals FW, Pomeroy KL, Goudsmit J, Asher DM, Gajdusek DC (1986) Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slidetest for antibody screening in Africa. Trop Geogr Med 38:209–214PubMed
45.
Van Regenmortel MHV, Fauquet CM, Bishop DHL, Carstens EB, Estes MK, Lemon SM, Maniloff J, Mayo MA, McGeoch DJ, Pringle CR, Wickner RB (2000) Virus taxonomy: The classification and nomenclature of viruses. The Seventh Report of the International Committee on Tasonomy of viruses (Book). Virus Taxonomy, VIIth report of ICTV. Academic Press, San Diego, p 1167
46.
Volchkov VE, Becker S, Volchkova VA, Ternovoj VA, Kotov AN, Netesov SV, Klenk HD (1995) GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 214:421–430CrossRefPubMed
47.
Volchkov VE, Feldmann H, Volchkva VA, Klenk HD (1998) Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Nat Acad Sci USA 95:5762–5767CrossRefPubMed
48.
Volchkov VE,Volchkova VA, Slenczka W, Klenk HD, Feldmann H (1998) Release of viral glycoproteins during Ebola virus infection. Virology 245:110–119CrossRefPubMed
49.
Wilson MB, Nakane PK (1976) The covalent coupling of proteins to periodate-oxidized sephadex: a new a approach to immunoadsorbent preparation. J Immunol Methods 12:171–181CrossRefPubMed
50.
World Health Organization (1976) Suspected viral haemorrhagic fever outbreaks in Sudan and Zaire. Wkly Epidemiol Rec 51:321
51.
World Health Organization (1992) Viral haemorrhagic fever in imported monkeys. Wkly Epidemiol Rec 67:142–143PubMed
52.
Zaki SR, Shieh WJ, Greer PW, Goldsmith CS, Ferebee T, Katshitshi J, Tshioko FK, Bwaka MA, Swanepoel R, Calain P, Khan AS, Lloyd E, Rollin PE, Ksiazek TG, Peters CJ (1999) A novel histochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179 [Suppl 1]:36–47
Metadaten
Titel
Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus
verfasst von
Andreas Lucht
Roland Grunow
Christian Otterbein
Peggy Möller
Heinz Feldmann
Stephan Becker
Publikationsdatum
01.11.2004
Verlag
Springer-Verlag
Erschienen in
Medical Microbiology and Immunology / Ausgabe 4/2004
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-003-0204-z

Weitere Artikel der Ausgabe 4/2004

Medical Microbiology and Immunology 4/2004 Zur Ausgabe

Original Investigation

Thrombin induces Sp1-mediated antiviral effects in cytomegalovirus-infected human retinal pigment epithelial cells

Original Investigation

Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae

Original Investigation

The functional interaction between CD98 and CD147 in regulation of virus-induced cell fusion and osteoclast formation

Original Investigation

Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosis

Original Investigation

Detection and quantification of Mycobacterium leprae in tissue samples by real-time PCR

Original Investigation

An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise